NCT02279095 · Interventional trial
An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)
Overall registry status Completed
Phase 2
Conditions Fibrodysplasia Ossificans Progressiva
Delaware Valley sites
- University of Pennsylvania, Center for FOP & Related Bone Disorders · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory